PLK1 Vanillin derivative compounds inducing selective degradation of PLK1

The present invention relates to novel compounds that induce selective degradation of PLK1, and more particularly, to a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase binding moiety are linked by a chemical linker. The present invention provides the compound, a metho...

Full description

Saved in:
Bibliographic Details
Main Authors KEUM YOUNG KANG, HYE GUK RYU, HWA JIN LEE, SEONG HOON KIM, SI WOO CHOI, JI HOON RYU, IM SUK MIN, SAN HA SON, SOO HEE RYU, BOAS NAM
Format Patent
LanguageEnglish
Korean
Published 08.10.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel compounds that induce selective degradation of PLK1, and more particularly, to a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase binding moiety are linked by a chemical linker. The present invention provides the compound, a method for manufacturing the same, and uses thereof. The compounds according to the present invention can be usefully used for the prevention or treatment of PLK1-related diseases. 본 발명은 PLK1의 선택적 분해를 유도하는 신규 화합물에 관한 것으로, 구체적으로 PLK1 결합 모이어티와 E3 유비퀴틴 라이게이즈 결합 모이어티가 화학적 링커로 연결된 이기능성 화합물에 관한 것이다. 본 발명은 상기 화합물, 이의 제조방법, 및 이의 용도 등을 제공한다. 본 발명에 따른 화합물들은 PLK1 관련 질환의 예방 또는 치료에 유용하게 사용될 수 있다.
Bibliography:Application Number: KR20210040038D